Purpose of the Procedure
- Determine if the fetus is Rh-positive or Rh-negative.
- Avoid unnecessary Anti-D injections if the fetus is Rh-negative.
- Prevent Rhesus disease and related pregnancy complications.
Book Fetal RhD Genotyping in Saudi Arabia | Lahalak Medical Platform
A non-invasive screening for Rh-negative mothers to accurately determine fetal RhD status, minimizing unnecessary Anti-D injections and ensuring proactive management for a safe and healthy pregnancy journey.
Scientific name: Non-Invasive Fetal RhD Genotyping
A precise laboratory test analyzing fetal cfDNA in maternal blood to identify the fetal RhD factor, helping manage Rh incompatibility and preventing potential pregnancy complications.
Service type
Advanced Laboratory Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Fetal cfDNA analysis
- Detailed medical report
Medical Service Information
Target Groups
- Pregnant women with Rh-negative blood type.
- Expectant mothers seeking to minimize unnecessary immunotherapy.
- Management of pregnancies at risk of blood group incompatibility.
Benefits of Non-Invasive Testing
- Zero risk of miscarriage compared to invasive methods.
- High accuracy rates exceeding 99%.
- Early detection from the 11th week of gestation.
Conditions & Notices
- Test should be performed after the 11th week of pregnancy
- Specifically for Rh-negative mothers
Medical services you might also like
